secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2026-08-28T21:02:54+00:00
Accession:  0001493152-26-040642
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SRX Global issues 3,579 Series C preferred shares in $2.86M debt-for-equity swap
--------------------------------------------------------------------------------

- Issued 3,579 Series C convertible preferred shares for $2,862,500, paid via assignment of CERO Therapeutics notes ($2,812,500 principal + $50,000 accrued interest).
- Series C converts at fixed $2.1888/share; alternate conversion at 95% of lowest VWAP after stockholder approval, 90% on triggering events.
- Company may redeem Series C at 125% of conversion amount; preferred ranks pari passu with Series A and B preferred.
- Registration rights agreement filed to register resale of underlying common shares and warrant shares.
- Transaction executed as unregistered offering under Section 4(a)(2)/Reg D; no cash proceeds received.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000149315226040642/0001493152-26-040642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000149315226040642/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-040642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer